Latest Revenue Growth News

Monadelphous Group Limited reported a robust FY25 with $2.27 billion revenue and $158 million net profit, underpinned by strong contract wins and growth in energy and resources sectors.

Monadelphous Group Limited has reported a robust 35% increase in net profit for the 2025 financial year, alongside a 7% revenue rise, prompting a notable dividend hike.

Challenger Limited reported a robust 48% increase in net profit after tax for FY2025, alongside a 4.6% rise in revenue and an 11.3% dividend hike, reflecting improved operational performance and financial resilience.

Sims Limited reported a 4.1% increase in sales revenue to A$7.494 billion for FY25, alongside a 48.1% jump in underlying EBITDA to A$430 million. Despite a statutory net loss, the company declared a fully franked final dividend of 13 cents per share, reflecting confidence amid market challenges and portfolio reshaping.

HUB24 Limited reported robust FY25 results with revenue climbing 24% to $406.6 million and underlying net profit after tax soaring 44%. The company’s platform funds under administration grew 34%, underpinning a 47% increase in fully franked dividends.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

Reliance Worldwide Corporation reported a solid 5.5% revenue increase and a 13.5% rise in net profit for FY25, driven by the full-year impact of its Holman Industries acquisition and strategic capital returns.

HMC Capital Limited reported a record FY25 profit of $265.2 million, driven by strategic acquisitions and growth in digital infrastructure and energy transition sectors. The company also declared a consistent dividend and strengthened its balance sheet with an increased undrawn debt facility.

Simonds Group reported a stable $665.6 million revenue for FY25, with normalised net profit after tax surging 90% to $5.7 million, driven by the acquisition of Dennis Family Homes and improved margins.

Simonds Group Limited reported steady revenue of $665.6 million for FY2025, alongside a modest net profit of $1.015 million, as it completed the strategic acquisition of Dennis Family Homes. The company is focused on integrating the acquisition and driving growth amid a recovering housing market.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.